Do all patients with congenital adrenal hyperplasia need to be on hydrocortisone three times a day in order to have normal growth?

Conclusions: Less than half of our patients with CAH were receiving TID HC. Reassuringly, growth parameters and other indices of disease control were equivalent between patients on conventional HC dosing and other therapeutic approaches. These results suggest that a range of glucocorticoid treatment regimens may be equally viable in children with CAH.
Source: Hormone Research in Paediatrics - Category: Endocrinology Source Type: research